Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel; Gemcitabine
- Indications Liver cancer
- Focus Therapeutic Use
- 07 Dec 2016 Biomarkers information updated
- 26 Apr 2008 Status change from in progress to completed, according to clinicaltrials.gov.
- 03 Sep 2005 New trial record.